Orbitrap Astral Zoom
Instrument Overview
Orbitrap Astral Zoom is Thermo Fisher’s next-generation high-resolution mass spectrometry platform. Built on Orbitrap Astral, it further improves sensitivity, dynamic range, and analytical throughput for next-generation proteomics, biomarker discovery, and high-throughput research.
Key Features
- Ultra-high sensitivity significantly improves low-abundance protein detection for micro-samples and rare samples.
- Ultra-high throughput supports large-scale batch analysis, shortens testing cycles, and meets clinical cohort and drug-screening needs.
- Excellent quantitative accuracy delivers stable, reliable quantitative results and improves consistency across samples.
- A wider dynamic range enables simultaneous detection of high- and low-abundance proteins in complex samples.
- High data reliability, repeatability, and stability support long-term operation and high-precision quantitative research.
Platform Applications
- Proteomics: discovery proteomics, DIA proteomics, label-free quantitative proteomics, TMT quantitative proteomics, and biomarker discovery
- Single-cell proteomics: single-cell protein expression analysis, cellular heterogeneity studies, and tumor microenvironment research
- Spatial proteomics: tissue-region differential analysis, tumor spatial heterogeneity studies, and spatially resolved protein-expression research
- Post-translational modifications: phosphoproteomics, acetylomics, ubiquitinomics, and methylomics
- Glycoproteomics: N-glycosylation analysis, O-glycosylation analysis, glycopeptide identification and quantification, and glycan-structure research
- Immunopeptidomics: MHC-I/MHC-II peptidomics, neoantigen discovery, and tumor immunology research
- Cross-linking mass spectrometry: protein interaction networks, protein complex analysis, and structural biology research
- Biopharma: monoclonal antibody characterization, ADC drug analysis, host-cell protein detection, and quality consistency evaluation
Shenzhen Wininnovate Bio Co., Ltd.
Innovative mass spectrometry and AI technologies provide protein and metabolite mass spectrometry multi-omics solutions for life science research, empowering the growth of the biotechnology, pharmaceutical, and healthcare industries.
